![Justin Xiang](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Justin Xiang
Oprichter bij Syno Partners LLC
Actieve functies van Justin Xiang
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
Seaport Diagnostics, Inc.
![]() Seaport Diagnostics, Inc. BiotechnologyHealth Technology Seaport Diagnostics, Inc. operates as a biotechnology company which develops treatments for genetically inherited diseases. It also offers DNA Tests for consumers across many categories such as nutrition, fitness, behavior tendencies, skincare, and more; provides consumers access to genetic information via mobile application; and manages human cell bank for future testing on regenerative medical therapies. The company was founded by Scott Schaus, Robin Y. Smith and Kate Blanchard on June 30, 2014 and is headquartered in Boston, MA. | Directeur/Bestuurslid | - | - |
Syno Partners LLC
![]() Syno Partners LLC Investment ManagersFinance Syno Partners LLC (Syno Partners) is a venture capital firm founded in 2015 by Justin Xiang and Joseph Weilgus. The firm is headquartered in New York. | Chief Investment Officer | 01-01-2015 | - |
Oprichter | 01-01-2015 | - |
Loopbaan van Justin Xiang
Eerdere bekende functies van Justin Xiang
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
LUNGLIFE AI, INC. | Directeur/Bestuurslid | - | 01-07-2021 |
Statistieken
Internationaal
Verenigde Staten | 3 |
China | 2 |
Operationeel
Director/Board Member | 2 |
Chief Investment Officer | 1 |
Founder | 1 |
Sectoraal
Health Services | 2 |
Health Technology | 2 |
Finance | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
LUNGLIFE AI, INC. | Health Services |
Bedrijven in privébezit | 2 |
---|---|
Seaport Diagnostics, Inc.
![]() Seaport Diagnostics, Inc. BiotechnologyHealth Technology Seaport Diagnostics, Inc. operates as a biotechnology company which develops treatments for genetically inherited diseases. It also offers DNA Tests for consumers across many categories such as nutrition, fitness, behavior tendencies, skincare, and more; provides consumers access to genetic information via mobile application; and manages human cell bank for future testing on regenerative medical therapies. The company was founded by Scott Schaus, Robin Y. Smith and Kate Blanchard on June 30, 2014 and is headquartered in Boston, MA. | Health Technology |
Syno Partners LLC
![]() Syno Partners LLC Investment ManagersFinance Syno Partners LLC (Syno Partners) is a venture capital firm founded in 2015 by Justin Xiang and Joseph Weilgus. The firm is headquartered in New York. | Finance |
- Beurs
- Insiders
- Justin Xiang
- Ervaring